Immunopathogenesis of inflammatory bowel diseases: new approaches for therapy?
Beglinger, C.
Schweizerische Medizinische Wochenschrift 128(1-2): 11-14
1998
ISSN/ISBN: 0036-7672 PMID: 9491461 Document Number: 487341
Document emailed within 1 workday
Related Documents
Tertychnyĭ, A.C.; Andreev, A.I.; Geboes, K. 2011: Current approaches to morphological diagnosis of inflammatory bowel diseases from endoscopic biopsy specimens Arkhiv Patologii 73(1): 40-47Drapkina, O.M.; Korneeva, O.N. 2016: Small bowel injuries due to nonsteroidal anti-inflammatory drugs and antiplatelet therapy. Approaches to prevention and treatment Terapevticheskii Arkhiv 88(12): 133-139
Oikawa, T.; Ito, G.; Hanawa, T. 2012: Kampo therapy for inflammatory bowel diseases Nihon Rinsho. Japanese Journal of Clinical Medicine 70(Suppl 1): 365-369
Dölle, W.; Daiss, W. 1988: Therapy of chronic inflammatory bowel diseases. Clinical aspects and therapy of drug-induced side effects Verhandlungen der Deutschen Gesellschaft für Innere Medizin 94: 184-191
Zuo, S.; Wang, X.; Liu, Y.-c.; Wang, P.-y. 2012: Therapy progression in surgery of inflammatory bowel diseases Zhonghua Wei Chang Wai Ke Za Zhi 15(8): 872-876
Ungebeuer, E.; Probst, M. 1981: Surgical therapy of inflammatory large bowel diseases Wiener Medizinische Wochenschrift 131(18): 443-447
Konečný, M.; Ehrmann, J.ří 2014: Advances in diagnosis and therapy of inflammatory bowel diseases Vnitrni Lekarstvi 60(7-8): 625-629
González, T.; Rodríguez-Lozano, B.; Hernández-Beriaín, J.A. 1991: New approaches to the therapy of diffuse inflammatory diseases of the connective tissue Medicina Clinica 97(11): 424-430
Lazebnik, L.B.; Knyazev, O.V.; Parfenov, A.I.; Ruchkina, I.N.; Shcherbakov, P.L.; Khomeriki, S.G.; Konoplyannikov, A.G. 2012: Optimization of cell therapy in patients with inflammatory bowel diseases Terapevticheskii Arkhiv 84(8): 10-17
Kniazev, O.V.; Parfenov, A.I.; Ruchkina, I.N.; Konopliannikova, A.G.; Drozdov, V.N.; Sagynbaeva, V.É; Ivkina, T.I. 2013: New possibilities for overcoming the secondary inefficiency of anti-cytokine therapy in patients with inflammatory bowel diseases Terapevticheskii Arkhiv 85(2): 57-60
Mayet, W.J.; Orth, T.; Schwarting, A.; Meyer zum Büschenfelde, K.H.; Gerken, G. 1996: Significance of antineutrophil cytoplasmic antibodies (ANCA) in diagnosis and immunopathogenesis of chronic inflammatory liver diseases Medizinische Klinik 91(6): 384-388
Megens-de Letter, M.A.; Visser, L.H.; van Doorn, P.A.; Savelkoul, H.F. 1999: Cytokines in the muscle tissue of idiopathic inflammatory myopathies: implications for immunopathogenesis and therapy European Cytokine Network 10(4): 471-478
Mekkel, G.; Barta, Z.; Ress, Z.; Gyimesi, E.; Sipka, S.án.; Zeher, M. 2005: Increased IgE-type antibody response to food allergens in irritable bowel syndrome and inflammatory bowel diseases Orvosi Hetilap 146(17): 797-802
Krzesiek, E.; Iwańczak, B. 2010: Assessment of fecal calprotectin concentration as inflammatory marker in inflammatory bowel diseases in children--preliminary report Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego 29(172): 241-246
Serghini, M.; Fekih, M.; Karoui, S.; Ben Mustapha, N.; Kallel, L.; Matri, S.; Boubaker, J.; Filali, A. 2010: Fertility and inflammatory bowel diseases La Tunisie Medicale 88(9): 623-628
Herrlinger, K.; Stange, E.F. 2004: Chronic inflammatory bowel diseases Deutsche Medizinische Wochenschrift 129(42): 2241-2250; Quiz 2251-2254
Rasenack, J.; Schölmerich, J. 1990: Inflammatory bowel diseases and the course of pregnancy Der Gynakologe 23(1): 11-17
El-Tawil, A.M. 2009: A new hypothesis on inflammatory bowel diseases European Review for Medical and Pharmacological Sciences 13(1): 66; Author Reply 67
Katschinski, B.; Logan, R.F.; Langman, M.J. 1989: Smoking and inflammatory bowel diseases Zeitschrift für Gastroenterologie 27(10): 614-618
Ardesia, M.; Villanacci, V.; Fries, W. 2015: The aged gut in inflammatory bowel diseases Minerva Gastroenterologica e Dietologica 61(4): 235-247